Literature DB >> 7962532

Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol.

A Inazu1, X C Jiang, T Haraki, K Yagi, N Kamon, J Koizumi, H Mabuchi, R Takeda, K Takata, Y Moriyama.   

Abstract

Genetic determinants of HDL cholesterol (HDL-C) levels in the general population are poorly understood. We previously described plasma cholesteryl ester transfer protein (CETP) deficiency due to an intron 14 G(+1)-to-A mutation(Int14 A) in several families with very high HDL-C levels in Japan. Subjects with HDL-C > or = 100 mg/dl (n = 130) were screened by PCR single strand conformational polymorphism analysis of the CETP gene. Two other mutations were identified by DNA sequencing or primer-mediated restriction map modification of PCR products: a novel intron 14 splice donor site mutation caused by a T insertion at position +3 from the exon14/intron14 boundary (Int14 T) and a missense mutation (Asp442 to Gly) within exon 15 (D442G). The Int14 T mutation was only found in one family. However, the D442G and Int14 A mutations were highly prevalent in subjects with HDL-C > or = 60 mg/dl, with combined allele frequencies of 9%, 12%, 21% and 43% for HDL-C 60-79, 80-99, 100-119, and > or = 120 mg/dl, respectively. Furthermore, prevalences of the D442G and Int14 A mutations were extremely high in a general sample of Japanese men (n = 236), with heterozygote frequencies of 7% and 2%, respectively. These two mutations accounted for about 10% of the total variance of HDL-C in this population. The phenotype in a genetic compound heterozygote (Int14 T and Int14 A) was similar to that of Int14 A homozygotes (no detectable CETP and markedly increased HDL-C), indicating that the Int14 T produces a null allele. In four D442G homozygotes, mean HDL-C levels (86 +/- 26 mg/dl) were lower than in Int14 A homozygotes (158 +/- 35 mg/dl), reflecting residual CETP activity in plasma. In 47 D442G heterozygotes, mean HDL-C levels were 91 +/- 23 mg/dl, similar to the level in D442G homozygotes, and significantly greater than mean HDL-C levels in Int14 A heterozygotes (69 +/- 15 mg/dl). Thus, the D442G mutation acts differently to the null mutations with weaker effects on HDL in the homozygous state and stronger effects in the heterozygotes, suggesting dominant expression of a partially defective allele. CETP deficiency, reflecting two prevalent mutations (D442G and Int14 A), is the first example of a genetic deficiency state which is sufficiently common to explain a significant fraction of the variation in HDL-C in the general population.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962532      PMCID: PMC305391          DOI: 10.1172/JCI117537

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  45 in total

1.  Report of the Second International Workshop on Human Chromosome 16 Mapping.

Authors:  D F Callen; C E Hildebrand; S Reeders
Journal:  Cytogenet Cell Genet       Date:  1992

2.  Very high values of serum high-density lipoprotein cholesterol.

Authors:  J B Weitzman; A O Vladutiu
Journal:  Arch Pathol Lab Med       Date:  1992-08       Impact factor: 5.534

3.  Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

Authors:  G G Rhoads; C L Gulbrandsen; A Kagan
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

4.  Serum lipoprotein lipid concentration and composition in homozygous and heterozygous patients with cholesteryl ester transfer protein deficiency.

Authors:  J Koizumi; A Inazu; K Yagi; I Koizumi; Y Uno; K Kajinami; S Miyamoto; P Moulin; A R Tall; H Mabuchi
Journal:  Atherosclerosis       Date:  1991-10       Impact factor: 5.162

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Enzymatic determination of total serum cholesterol.

Authors:  C C Allain; L S Poon; C S Chan; W Richmond; P C Fu
Journal:  Clin Chem       Date:  1974-04       Impact factor: 8.327

7.  Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia.

Authors:  A Inazu; J Koizumi; H Mabuchi; K Kajinami; R Takeda
Journal:  Horm Metab Res       Date:  1992-06       Impact factor: 2.936

8.  Identification of a sequence within the C-terminal 26 amino acids of cholesteryl ester transfer protein responsible for binding a neutralizing monoclonal antibody and necessary for neutral lipid transfer activity.

Authors:  S Wang; L Deng; R W Milne; A R Tall
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

9.  Increased production of apolipoprotein A-I associated with elevated plasma levels of high-density lipoproteins, apolipoprotein A-I, and lipoprotein A-I in a patient with familial hyperalphalipoproteinemia.

Authors:  D J Rader; J R Schaefer; P Lohse; K Ikewaki; F Thomas; W A Harris; L A Zech; C A Dujovne; H B Brewer
Journal:  Metabolism       Date:  1993-11       Impact factor: 8.694

10.  Genetic determination of high-density lipoprotein-cholesterol and apolipoprotein A-1 plasma levels in a family study of cardiac catheterization patients.

Authors:  V L Prenger; T H Beaty; P O Kwiterovich
Journal:  Am J Hum Genet       Date:  1992-11       Impact factor: 11.025

View more
  41 in total

Review 1.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 2.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

3.  TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.

Authors:  Dilara Kaman; Necip İlhan; Nevin İlhan; Mehmet Akbulut
Journal:  Bosn J Basic Med Sci       Date:  2015-02-01       Impact factor: 3.363

4.  Cholesteryl ester transfer protein, coronary calcium, and intima-media thickness of the carotid artery in middle-age Japanese men.

Authors:  Tomonori Okamura; Akira Sekikawa; Takashi Kadowaki; Aiman El-Saed; Robert D Abbott; J David Curb; Daniel Edmundowicz; Yasuyuki Nakamura; Kiyoshi Murata; Atsunori Kashiwagi; Kim Sutton-Tyrrell; Rhobert W Evans; Joseph M Zmuda; Hiroshi Maegawa; Atsushi Hozawa; Ken-Ichi Mitsunami; Yoshihiko Nishio; Iva Miljkovic-Gacic; Minoru Horie; Naomi Miyamatsu; Yoshitaka Murakami; Lewis H Kuller; Hirotsugu Ueshima
Journal:  Am J Cardiol       Date:  2009-07-18       Impact factor: 2.778

5.  Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element.

Authors:  Y Luo; A R Tall
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

Review 7.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

8.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

9.  Fine mapping and association studies of a high-density lipoprotein cholesterol linkage region on chromosome 16 in French-Canadian subjects.

Authors:  Zari Dastani; Päivi Pajukanta; Michel Marcil; Nicholas Rudzicz; Isabelle Ruel; Swneke D Bailey; Jenny C Lee; Mathieu Lemire; Janet Faith; Jill Platko; John Rioux; Thomas J Hudson; Daniel Gaudet; James C Engert; Jacques Genest
Journal:  Eur J Hum Genet       Date:  2009-10-21       Impact factor: 4.246

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.